Literature DB >> 24691479

Multifocal epithelial tumors and field cancerization: stroma as a primary determinant.

G Paolo Dotto.   

Abstract

It is increasingly evident that cancer results from altered organ homeostasis rather than from deregulated control of single cells or groups of cells. This applies especially to epithelial cancer, the most common form of human solid tumors and a major cause of cancer lethality. In the vast majority of cases, in situ epithelial cancer lesions do not progress into malignancy, even if they harbor many of the genetic changes found in invasive and metastatic tumors. While changes in tumor stroma are frequently viewed as secondary to changes in the epithelium, recent evidence indicates that they can play a primary role in both cancer progression and initiation. These processes may explain the phenomenon of field cancerization, i.e., the occurrence of multifocal and recurrent epithelial tumors that are preceded by and associated with widespread changes of surrounding tissue or organ "fields."

Entities:  

Mesh:

Year:  2014        PMID: 24691479      PMCID: PMC3973113          DOI: 10.1172/JCI72589

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  159 in total

1.  DNA methylation and field cancerization.

Authors:  Kavitha Ramachandran; Rakesh Singal
Journal:  Epigenomics       Date:  2012-06       Impact factor: 4.778

Review 2.  A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

Authors:  Boudewijn J M Braakhuis; Maarten P Tabor; J Alain Kummer; C René Leemans; Ruud H Brakenhoff
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

3.  Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.

Authors:  Tae-Won Kang; Tetyana Yevsa; Norman Woller; Lisa Hoenicke; Torsten Wuestefeld; Daniel Dauch; Anja Hohmeyer; Marcus Gereke; Ramona Rudalska; Anna Potapova; Marcus Iken; Mihael Vucur; Siegfried Weiss; Mathias Heikenwalder; Sadaf Khan; Jesus Gil; Dunja Bruder; Michael Manns; Peter Schirmacher; Frank Tacke; Michael Ott; Tom Luedde; Thomas Longerich; Stefan Kubicka; Lars Zender
Journal:  Nature       Date:  2011-11-09       Impact factor: 49.962

4.  Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice.

Authors:  Hiroyuki Miyoshi; Masayuki Nakau; Tomo-o Ishikawa; Michael F Seldin; Masanobu Oshima; Makoto M Taketo
Journal:  Cancer Res       Date:  2002-04-15       Impact factor: 12.701

Review 5.  Cancer as an evolutionary and ecological process.

Authors:  Lauren M F Merlo; John W Pepper; Brian J Reid; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2006-11-16       Impact factor: 60.716

6.  Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets.

Authors:  Koichi Fukino; Lei Shen; Satoshi Matsumoto; Carl D Morrison; George L Mutter; Charis Eng
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

7.  Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis.

Authors:  Karin Muller-Decker; Gitta Neufang; Irina Berger; Melanie Neumann; Friedrich Marks; Gerhard Furstenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

Review 8.  Actinic keratosis: review of the literature and new patents.

Authors:  Carmen Cantisani; Federico De Gado; Martina Ulrich; Ugo Bottoni; Francis Iacobellis; Antonio G Richetta; Stefano Calvieri
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2013-05

Review 9.  Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells.

Authors:  Urszula M Polanska; Akira Orimo
Journal:  J Cell Physiol       Date:  2013-08       Impact factor: 6.384

10.  Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis.

Authors:  X Li; V Placencio; J M Iturregui; C Uwamariya; A-R Sharif-Afshar; T Koyama; S W Hayward; N A Bhowmick
Journal:  Oncogene       Date:  2008-08-25       Impact factor: 9.867

View more
  59 in total

1.  CSL-p53: From senescence to CAF activation.

Authors:  Maria-Giuseppina Procopio; Csaba Laszlo; G Paolo Dotto
Journal:  Cell Cycle       Date:  2016-01-06       Impact factor: 4.534

Review 2.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

3.  Negative control of CSL gene transcription by stress/DNA damage response and p53.

Authors:  Elena Menietti; Xiaoying Xu; Paola Ostano; Jean-Marc Joseph; Karine Lefort; G Paolo Dotto
Journal:  Cell Cycle       Date:  2016-05-10       Impact factor: 4.534

Review 4.  Inflammation fuels tumor progress and metastasis.

Authors:  Jingyi Liu; Pengnian Charles Lin; Binhua P Zhou
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

5.  High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting.

Authors:  Tihana Džombeta; Božo Krušlin
Journal:  Pathol Oncol Res       Date:  2017-07-27       Impact factor: 3.201

6.  Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fire.

Authors:  Jung H Suh; Julie D Saba
Journal:  Transl Cancer Res       Date:  2015-10-01       Impact factor: 1.241

Review 7.  Squamous Cell Cancers: A Unified Perspective on Biology and Genetics.

Authors:  G Paolo Dotto; Anil K Rustgi
Journal:  Cancer Cell       Date:  2016-05-09       Impact factor: 31.743

8.  Deubiquitylating enzyme, USP9X, regulates proliferation of cells of head and neck cancer lines.

Authors:  D M Nanayakkara; M N Nguyen; S A Wood
Journal:  Cell Prolif       Date:  2016-07-04       Impact factor: 6.831

9.  The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI.

Authors:  Sandro Goruppi; Maria-Giuseppina Procopio; Seunghee Jo; Andrea Clocchiatti; Victor Neel; G Paolo Dotto
Journal:  Cell Rep       Date:  2017-09-05       Impact factor: 9.423

Review 10.  Cancer-associated fibroblasts in hepatocellular carcinoma.

Authors:  Norio Kubo; Kenichiro Araki; Hiroyuki Kuwano; Ken Shirabe
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.